Clinical Trials Directory

Trials / Unknown

UnknownNCT00136370

Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn

Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
8,000 (estimated)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
Female
Age
15 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate whether use of the disinfectant chlorhexidine administered to the birth canal during labour and newborn at delivery can protect a woman and her baby from bacterial infections after birth. If effective, this could be used as an inexpensive alternative to antibiotics to prevent newborn infections in resource-poor countries.

Detailed description

We are conducting a randomized, controlled clinical trial in Soweto, South Africa to evaluate the efficacy of 0.5% chlorhexidine wipes of the birth canal during labour and of the infant at birth in reducing 1) vertical transmission of leading pathogenic bacteria from mother to child during labour and delivery, and 2) incidence of neonatal sepsis and maternal peripartum infection, in comparison to external genitalia sterile water wipes. In conjunction with this, we will compare vaginal carriage of bacteria commonly associated with neonatal sepsis and maternal peripartum infection among HIV-infected and non-infected pregnant women who deliver at the only public hospital in Soweto, and will characterize the burden of disease and risk factors for maternal peripartum infection and serious neonatal infections in this population by conducting active prospective surveillance.

Conditions

Interventions

TypeNameDescription
DRUGChlorhexidine
PROCEDUREBirth canal wipe
PROCEDUREsterile water external genital wipe

Timeline

Start date
2004-04-01
Completion
2007-11-01
First posted
2005-08-29
Last updated
2007-09-24

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT00136370. Inclusion in this directory is not an endorsement.